Global Oncology Biosimilars Market Research Report 2021

Publisher Name :
Date: 13-Jan-2021
No. of pages: 94
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Monoclonal Antibody

- Hematopoietic Agents

- G-CSF

- Others

Segment by Application

- Retail Pharmacies

- Hospital Pharmacy

- Online Pharmacy

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Celltrion

- Biocon

- Dr. Reddy's Laboratories

- STADA Arzneimittel AG

- Intas Pharmaceuticals

- Pfizer

- Sandoz International

- Teva Pharmaceutical Industries Ltd

- Apotex

- BIOCAD

Global Oncology Biosimilars Market Research Report 2021

Table of Contents
1 Oncology Biosimilars Market Overview
1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Oncology Biosimilars Segment by Type
1.2.1 Global Oncology Biosimilars Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Monoclonal Antibody
1.2.3 Hematopoietic Agents
1.2.4 G-CSF
1.2.5 Others
1.3 Oncology Biosimilars Segment by Application
1.3.1 Oncology Biosimilars Sales Comparison by Application: (2021-2027)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacy
1.3.4 Online Pharmacy
1.4 Global Oncology Biosimilars Market Size Estimates and Forecasts
1.4.1 Global Oncology Biosimilars Revenue 2016-2027
1.4.2 Global Oncology Biosimilars Sales 2016-2027
1.4.3 Oncology Biosimilars Market Size by Region: 2016 Versus 2021 Versus 2027
2 Oncology Biosimilars Market Competition by Manufacturers
2.1 Global Oncology Biosimilars Sales Market Share by Manufacturers (2016-2021)
2.2 Global Oncology Biosimilars Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Oncology Biosimilars Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Oncology Biosimilars Manufacturing Sites, Area Served, Product Type
2.5 Oncology Biosimilars Market Competitive Situation and Trends
2.5.1 Oncology Biosimilars Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oncology Biosimilars Players Market Share by Revenue
2.5.3 Global Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oncology Biosimilars Retrospective Market Scenario by Region
3.1 Global Oncology Biosimilars Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Oncology Biosimilars Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Oncology Biosimilars Market Facts & Figures by Country
3.3.1 North America Oncology Biosimilars Sales by Country
3.3.2 North America Oncology Biosimilars Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oncology Biosimilars Market Facts & Figures by Country
3.4.1 Europe Oncology Biosimilars Sales by Country
3.4.2 Europe Oncology Biosimilars Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oncology Biosimilars Market Facts & Figures by Region
3.5.1 Asia Pacific Oncology Biosimilars Sales by Region
3.5.2 Asia Pacific Oncology Biosimilars Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oncology Biosimilars Market Facts & Figures by Country
3.6.1 Latin America Oncology Biosimilars Sales by Country
3.6.2 Latin America Oncology Biosimilars Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oncology Biosimilars Market Facts & Figures by Country
3.7.1 Middle East and Africa Oncology Biosimilars Sales by Country
3.7.2 Middle East and Africa Oncology Biosimilars Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Oncology Biosimilars Historic Market Analysis by Type
4.1 Global Oncology Biosimilars Sales Market Share by Type (2016-2021)
4.2 Global Oncology Biosimilars Revenue Market Share by Type (2016-2021)
4.3 Global Oncology Biosimilars Price by Type (2016-2021)
5 Global Oncology Biosimilars Historic Market Analysis by Application
5.1 Global Oncology Biosimilars Sales Market Share by Application (2016-2021)
5.2 Global Oncology Biosimilars Revenue Market Share by Application (2016-2021)
5.3 Global Oncology Biosimilars Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Celltrion
6.1.1 Celltrion Corporation Information
6.1.2 Celltrion Description and Business Overview
6.1.3 Celltrion Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Celltrion Product Portfolio
6.1.5 Celltrion Recent Developments/Updates
6.2 Biocon
6.2.1 Biocon Corporation Information
6.2.2 Biocon Description and Business Overview
6.2.3 Biocon Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Biocon Product Portfolio
6.2.5 Biocon Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Dr. Reddy's Laboratories Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 STADA Arzneimittel AG
6.4.1 STADA Arzneimittel AG Corporation Information
6.4.2 STADA Arzneimittel AG Description and Business Overview
6.4.3 STADA Arzneimittel AG Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.4.4 STADA Arzneimittel AG Product Portfolio
6.4.5 STADA Arzneimittel AG Recent Developments/Updates
6.5 Intas Pharmaceuticals
6.5.1 Intas Pharmaceuticals Corporation Information
6.5.2 Intas Pharmaceuticals Description and Business Overview
6.5.3 Intas Pharmaceuticals Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Intas Pharmaceuticals Product Portfolio
6.5.5 Intas Pharmaceuticals Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pfizer Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sandoz International
6.6.1 Sandoz International Corporation Information
6.6.2 Sandoz International Description and Business Overview
6.6.3 Sandoz International Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sandoz International Product Portfolio
6.7.5 Sandoz International Recent Developments/Updates
6.8 Teva Pharmaceutical Industries Ltd
6.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.8.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.8.3 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Teva Pharmaceutical Industries Ltd Product Portfolio
6.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Apotex Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 BIOCAD
6.10.1 BIOCAD Corporation Information
6.10.2 BIOCAD Description and Business Overview
6.10.3 BIOCAD Oncology Biosimilars Sales, Revenue and Gross Margin (2016-2021)
6.10.4 BIOCAD Product Portfolio
6.10.5 BIOCAD Recent Developments/Updates
7 Oncology Biosimilars Manufacturing Cost Analysis
7.1 Oncology Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oncology Biosimilars
7.4 Oncology Biosimilars Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oncology Biosimilars Distributors List
8.3 Oncology Biosimilars Customers
9 Oncology Biosimilars Market Dynamics
9.1 Oncology Biosimilars Industry Trends
9.2 Oncology Biosimilars Growth Drivers
9.3 Oncology Biosimilars Market Challenges
9.4 Oncology Biosimilars Market Restraints
10 Global Market Forecast
10.1 Oncology Biosimilars Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oncology Biosimilars by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Oncology Biosimilars by Type (2022-2027)
10.2 Oncology Biosimilars Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oncology Biosimilars by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Oncology Biosimilars by Application (2022-2027)
10.3 Oncology Biosimilars Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oncology Biosimilars by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Oncology Biosimilars by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Oncology Biosimilars Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Oncology Biosimilars Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Oncology Biosimilars Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Oncology Biosimilars Covered in This Study
Table 5. Global Oncology Biosimilars Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Oncology Biosimilars Sales Share by Manufacturers (2016-2021)
Table 7. Global Oncology Biosimilars Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Oncology Biosimilars Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Oncology Biosimilars Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Oncology Biosimilars Manufacturing Sites and Area Served
Table 11. Manufacturers Oncology Biosimilars Product Type
Table 12. Global Oncology Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oncology Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Biosimilars as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oncology Biosimilars Sales by Region (2016-2021) & (K Units)
Table 16. Global Oncology Biosimilars Sales Market Share by Region (2016-2021)
Table 17. Global Oncology Biosimilars Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Oncology Biosimilars Sales by Country (2016-2021) & (K Units)
Table 19. North America Oncology Biosimilars Sales Market Share by Country (2016-2021)
Table 20. North America Oncology Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Oncology Biosimilars Revenue Market Share by Country (2016-2021)
Table 22. Europe Oncology Biosimilars Sales by Country (2016-2021) & (K Units)
Table 23. Europe Oncology Biosimilars Sales Market Share by Country (2016-2021)
Table 24. Europe Oncology Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Oncology Biosimilars Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Oncology Biosimilars Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Oncology Biosimilars Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Oncology Biosimilars Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Oncology Biosimilars Revenue Market Share by Region (2016-2021)
Table 30. Latin America Oncology Biosimilars Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Oncology Biosimilars Sales Market Share by Country (2016-2021)
Table 32. Latin America Oncology Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Oncology Biosimilars Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Oncology Biosimilars Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Oncology Biosimilars Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Oncology Biosimilars Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Oncology Biosimilars Revenue Market Share by Country (2016-2021)
Table 38. Global Oncology Biosimilars Sales (K Units) by Type (2016-2021)
Table 39. Global Oncology Biosimilars Sales Market Share by Type (2016-2021)
Table 40. Global Oncology Biosimilars Revenue (Million US$) by Type (2016-2021)
Table 41. Global Oncology Biosimilars Revenue Share by Type (2016-2021)
Table 42. Global Oncology Biosimilars Price (US$/Unit) by Type (2016-2021)
Table 43. Global Oncology Biosimilars Sales (K Units) by Application (2016-2021)
Table 44. Global Oncology Biosimilars Sales Market Share by Application (2016-2021)
Table 45. Global Oncology Biosimilars Revenue (Million US$) by Application (2016-2021)
Table 46. Global Oncology Biosimilars Revenue Share by Application (2016-2021)
Table 47. Global Oncology Biosimilars Price (US$/Unit) by Application (2016-2021)
Table 48. Celltrion Corporation Information
Table 49. Celltrion Description and Business Overview
Table 50. Celltrion Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Celltrion Oncology Biosimilars Product
Table 52. Celltrion Recent Developments/Updates
Table 53. Biocon Corporation Information
Table 54. Biocon Description and Business Overview
Table 55. Biocon Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Biocon Oncology Biosimilars Product
Table 57. Biocon Recent Developments/Updates
Table 58. Dr. Reddy's Laboratories Corporation Information
Table 59. Dr. Reddy's Laboratories Description and Business Overview
Table 60. Dr. Reddy's Laboratories Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Dr. Reddy's Laboratories Oncology Biosimilars Product
Table 62. Dr. Reddy's Laboratories Recent Developments/Updates
Table 63. STADA Arzneimittel AG Corporation Information
Table 64. STADA Arzneimittel AG Description and Business Overview
Table 65. STADA Arzneimittel AG Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. STADA Arzneimittel AG Oncology Biosimilars Product
Table 67. STADA Arzneimittel AG Recent Developments/Updates
Table 68. Intas Pharmaceuticals Corporation Information
Table 69. Intas Pharmaceuticals Description and Business Overview
Table 70. Intas Pharmaceuticals Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Intas Pharmaceuticals Oncology Biosimilars Product
Table 72. Intas Pharmaceuticals Recent Developments/Updates
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Business Overview
Table 75. Pfizer Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Pfizer Oncology Biosimilars Product
Table 77. Pfizer Recent Developments/Updates
Table 78. Sandoz International Corporation Information
Table 79. Sandoz International Description and Business Overview
Table 80. Sandoz International Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Sandoz International Oncology Biosimilars Product
Table 82. Sandoz International Recent Developments/Updates
Table 83. Teva Pharmaceutical Industries Ltd Corporation Information
Table 84. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 85. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product
Table 87. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 88. Apotex Corporation Information
Table 89. Apotex Description and Business Overview
Table 90. Apotex Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Apotex Oncology Biosimilars Product
Table 92. Apotex Recent Developments/Updates
Table 93. BIOCAD Corporation Information
Table 94. BIOCAD Description and Business Overview
Table 95. BIOCAD Oncology Biosimilars Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. BIOCAD Oncology Biosimilars Product
Table 97. BIOCAD Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Oncology Biosimilars Distributors List
Table 101. Oncology Biosimilars Customers List
Table 102. Oncology Biosimilars Market Trends
Table 103. Oncology Biosimilars Growth Drivers
Table 104. Oncology Biosimilars Market Restraints
Table 105. Global Oncology Biosimilars Sales Forecast by Type (2022-2027) & (K Units)
Table 106. Global Oncology Biosimilars Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Oncology Biosimilars Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Oncology Biosimilars Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Oncology Biosimilars Sales Forecast by Application (2022-2027) & (K Units)
Table 110. Global Oncology Biosimilars Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Oncology Biosimilars Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Oncology Biosimilars Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Oncology Biosimilars Sales Forecast by Region (2022-2027) & (K Units)
Table 114. Global Oncology Biosimilars Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Oncology Biosimilars Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Oncology Biosimilars Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oncology Biosimilars
Figure 2. Global Oncology Biosimilars Market Share by Type in 2020 & 2027
Figure 3. Monoclonal Antibody Product Picture
Figure 4. Hematopoietic Agents Product Picture
Figure 5. G-CSF Product Picture
Figure 6. Others Product Picture
Figure 7. Global Oncology Biosimilars Market Share by Application in 2020 & 2027
Figure 8. Retail Pharmacies
Figure 9. Hospital Pharmacy
Figure 10. Online Pharmacy
Figure 11. Global Oncology Biosimilars Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Oncology Biosimilars Market Size 2016-2027 (US$ Million)
Figure 13. Global Oncology Biosimilars Sales 2016-2027 (K Units)
Figure 14. Global Oncology Biosimilars Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Oncology Biosimilars Sales Share by Manufacturers in 2020
Figure 16. Global Oncology Biosimilars Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Oncology Biosimilars Players: Market Share by Revenue in 2020
Figure 18. Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Oncology Biosimilars Sales Market Share by Region (2016-2021)
Figure 20. Global Oncology Biosimilars Sales Market Share by Region in 2020
Figure 21. Global Oncology Biosimilars Revenue Market Share by Region (2016-2021)
Figure 22. Global Oncology Biosimilars Revenue Market Share by Region in 2020
Figure 23. U.S. Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Oncology Biosimilars Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Oncology Biosimilars by Type (2016-2021)
Figure 48. Sales Market Share of Oncology Biosimilars by Application (2016-2021)
Figure 49. Sales Market Share of Oncology Biosimilars by Application in 2020
Figure 50. Revenue Share of Oncology Biosimilars by Application (2016-2021)
Figure 51. Revenue Share of Oncology Biosimilars by Application in 2020
Figure 52. Manufacturing Cost Structure of Oncology Biosimilars
Figure 53. Manufacturing Process Analysis of Oncology Biosimilars
Figure 54. Oncology Biosimilars Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
  • Global Adalimumab Biosimilar Market Research Report 2021
    Published: 21-Jan-2021        Price: US 2900 Onwards        Pages: 122
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablet - Oral Solution Segment by Application - Hospital Pharmacy - Retail Pharmacy......
  • Global Biologics and Biosimilars Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 117
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Monoclonal Antibodies - Interferon - Erythropoietin - Insulin - Vaccines - Others......
  • Global Biologics and Biosimilars Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 14-Jan-2021        Price: US 3500 Onwards        Pages: 104
    Biosimilars are biomedical products that are almost identical to the original products made by different companies. Biosimilars are officially recognized versions of the original "innovator" products that can be produced when the original product patent expires. Reference to innovative products is an integral part of the approval. Based on the Biologics and Biosimilars market development status, competitive landscape and development model in different regions of the world, this report is ......
  • Global Oncology Biosimilars Market Research Report 2021
    Published: 13-Jan-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Monoclonal Antibody - Hematopoietic Agents - G-CSF - Others Segment by Application......
  • Global Follow-On-Biologics Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 12-Jan-2021        Price: US 3500 Onwards        Pages: 114
    Based on the Follow-On-Biologics market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in deta......
  • Global Biosimilars Market Research Report 2021
    Published: 11-Jan-2021        Price: US 2900 Onwards        Pages: 136
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) - Recombinant Glycosylated Proteins ......
  • Global Biosimilars Market Growth 2020-2025
    Published: 28-Dec-2020        Price: US 3660 Onwards        Pages: 178
    According to this study, over the next five years the Biosimilars market will register a 18.6%% CAGR in terms of revenue, the global market size will reach $ 9628.7 million by 2025, from $ 4859.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilars business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars market by product type, app......
  • Global Biosimilars Market Outlook 2021
    Published: 18-Dec-2020        Price: US 2900 Onwards        Pages: 130
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type, the Biosimilars market is segmented into - Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) - Reco......
  • Global Biosimilars-On-Biologics Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 17-Dec-2020        Price: US 3500 Onwards        Pages: 127
    Based on the Biosimilars-On-Biologics market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all ana......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs